MS Speaks
Here for 17 years--for people with an interest in multiple sclerosis
Welcome,
Guest
. Please
login
or
register
.
1 Hour
1 Day
1 Week
1 Month
Forever
Login with username, password and session length
This topic
This board
Entire forum
Home
Search
Today's Posts
Contact
Login
Register
MS Speaks 5/06 to 11/13
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
LEMTRADA (Campath, alemtuzumab)
»
FDA rejects MS drug Lemtrada (alemtuzumab, Campath)
»
Message #130
« previous
next »
Print
Pages: [
1
]
Author
Topic: FDA rejects MS drug Lemtrada (alemtuzumab, Campath) (Read 317 times)
0 Members and 1 Guest are viewing this topic.
agate
Administrator
Posts: 9842
MS diagnosed 1980
Location: Pacific Northwest
Re: FDA rejects MS drug Lemtrada (alemtuzumab, Campath)
«
on:
January 20, 2014, 07:25:40 pm »
The FDA has come in for some criticism about its rejection of alemtuzumab, as outlined in this
blogpost from the MS Discovery Forum
(January 7, 2014).
Report to moderator
Logged
MS Speaks--online for 17 years
SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Print
Pages: [
1
]
« previous
next »
MS Speaks
»
Forum
»
Multiple Sclerosis
»
TREATMENTS
»
LEMTRADA (Campath, alemtuzumab)
»
FDA rejects MS drug Lemtrada (alemtuzumab, Campath)
»
Message #130